Patency 2 Research Study

The PI of this project was: David Melnick, MD

This project was funded by: Proteon Therapeutics

The term of this project was: June 2016 to February 2017

The number of subjects scanned during this project was: 20

To assess the efficacy and safety of investigational drug administered immediately after radiocephalic arteriovenous fistula (AVF) creation.